Singapore markets closed

Straits Times Index
3,300.04
-3.15(-0.10%)
S&P 500
5,180.74
+52.95(+1.03%)
Dow
38,852.27
+176.59(+0.46%)
Nasdaq
16,349.25
+192.92(+1.19%)
Bitcoin USD
63,657.42
+78.31(+0.12%)
CMC Crypto 200
1,319.44
-45.68(-3.35%)

BMY Jan 2025 72.500 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

28.05

0.00

(0.00%)

As of 02:51PM EDT. Market open.

Business Wire
Bristol Myers Squibb to Participate in Upcoming Investor Conferences
PRINCETON, N.J., May 07, 2024--Bristol Myers Squibb to Participate in Upcoming Investor Conferences
Business Wire
U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
PRINCETON, N.J., May 06, 2024--U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
Business Wire
European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite...
PRINCETON, N.J., May 06, 2024--European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line....